| |
Audit
|
Corporate Governance and Nominating
|
Compensation
|
Scientific
|
 Joseph L. von Rosenberg, III 
|
|
|
|
|
 Chairman of the Board
Joseph L. von Rosenberg III has served as Chairman of the Board since November 2006. Prior to that, Mr. von Rosenberg served as President, Chief Executive Officer and a Director of the Company since July 1997. Previously, Mr. von Rosenberg served as Executive Vice President, General Counsel, and Corporate Secretary. Mr. von Rosenberg has a B.A. from Clemson University and a J.D. from Tulane University School of Law.
|
Holdings: 13,000 shares
View Transactions
|
| Date |
Type |
Shares Traded |
Price Range |
| Nov 18, 2011 |
Buy |
1,500 |
7.39 |
| Nov 17, 2011 |
Buy |
4,000 |
6.99 |
| Mar 25, 2011 |
Sell |
28,876 |
14.40 - 14.63 |
| Mar 25, 2011 |
Option Execute |
28,876 |
4.02 |
|
Dr. Gary L. Allee 
|
|
|
|
|
Dr. Gary L. Allee has been a director of the Company since May 1998. Dr. Allee is a professor of Swine Nutrition at the University of Missouri. Dr. Allee has served as President and as a member of the Board of Directors of the Midwest Section of the American Society of Animal Science. He has B.S. and M.S. degrees in Animal Husbandry and Swine Nutrition from the University of Missouri and a Ph.D. in Nutritional Sciences from the University of Illinois.
|
|
Gary R. Goodwin
|
|
|
|
|
Gary R. Goodwin is a Principal and the Vice President of Crude Oil Marketing for Texon, a privately held crude oil marketing company.
|
|
Paul M. Kearns
|
|
|
|
|
Paul M. Kearns is also a Director at Price Forbes Ltd., a London-based insurance brokerage firm that is the successor to Prentis, Donegan & Partners, Ltd. A citizen of the United Kingdom, Mr. Kearns has more than 20 years of experience in the global risk management and insurance industries.
|
Holdings: 0 shares
View Transactions
|
| Date |
Type |
Shares Traded |
Price Range |
| Mar 24, 2011 |
Sell |
25,100 |
14.36 - 14.55 |
| Mar 24, 2011 |
Option Execute |
25,100 |
2.21 - 4.70 |
| Mar 24, 2011 |
Sell |
10,000 |
14.13 - 14.25 |
| Mar 24, 2011 |
Option Execute |
10,000 |
8.61 |
| Mar 24, 2011 |
Sell |
40,000 |
14.25 - 14.36 |
| Mar 24, 2011 |
Option Execute |
40,000 |
4.77 - 6.14 |
| Mar 23, 2011 |
Sell |
9,100 |
13.91 - 13.99 |
| Mar 23, 2011 |
Option Execute |
9,100 |
2.21 |
|
|
Dr. William E. M. Lands
|
|
|
|
|
In February 2002, Dr. William E. M. Lands retired as Senior Scientific Advisor to the Director of the National Institute on Alcohol Abuse and Alcoholism, a position he assumed after serving as Head of the Department of Biological Chemistry at the University of Illinois Medical Center. Dr. Lands has a B.S. Degree in Chemistry from the University of Michigan and a Ph.D. in Biological Chemistry from the University of Illinois.
|
Holdings: 0 shares
View Transactions
|
| Date |
Type |
Shares Traded |
Price Range |
| Mar 15, 2012 |
Sell |
10,000 |
7.93 |
| Mar 15, 2012 |
Option Execute |
10,000 |
4.70 |
| Mar 17, 2011 |
Sell |
10,000 |
12.30 |
| Mar 17, 2011 |
Option Execute |
10,000 |
2.15 |
| Apr 13, 2010 |
Sell |
10,000 |
5.75 - 5.84 |
| Apr 13, 2010 |
Option Execute |
10,000 |
2.03 |
|
|
Harry O. Nicodemus, IV
|
|
|
|
|
Since June 2008, Harry O. Nicodemus IV served as the Chief Financial Officer of Awty School International, Inc. Prior to this, Mr. Nicodemus served as a Director at Outsource Partners International, and as Vice President, Chief Financial Officer, Chief Accounting Officer, Secretary and Compliance Officer of Equus Capital Management Corporation. Mr. Nicodemus was Vice President and Chief Accounting Officer of US Liquids, Inc. A Certified Public Accountant, he has held senior financial and accounting positions with various public companies and also practiced accounting with a national accounting firm.
|
|
David A. Owen
|
|
|
|
|
Mr. Owen serves as Deputy Chairman of Greenebaum Doll & McDonald PLLC representing businesses in a wide variety of complex commercial litigation matters. Mr. Owen's litigation practice includes environmental, agribusiness, toxic tort, anti-trust, construction, environmental permitting and enforcement matters. Mr. Owen received his B.S., Chemical Engineering from Clemson University in 1984 and his J.D. from Northern Kentucky University, Salmon P. Chase College of Law in 1987.
|
|
Dr. Jonathan Shepherd
|
|
|
|
|
Dr. Jonathan Shepherd served as Director General of The International Fishmeal and Fish Oil Organization (IFFO), an international non-profit organization which represents fish meal and fish oil producers and related trades throughout the world, from 2004 to 2011. Prior to this, Dr. Shepherd was Group Managing Director of BioMar, a fish feed company based in Denmark. Dr. Shepherd also held a series of senior positions with Unilever, Peter Hand and Norsk Hydro in connection with fish farming, pharmaceuticals, and feed manufacturing. Dr. Shepherd has a BVSc from Liverpool Veterinary School and a PhD from Stirling University.
|
|
David W. Wehlmann
|
|
|
|
|
Mr. Wehlmann served as Executive Vice President, Investor Relations of Precision Drilling Corporation, a publicly traded oilfield services company, until March 2012. He assumed this position in December 2008 upon the acquisition of Grey Wolf, Inc. by Precision Drilling Corporation. Mr. Wehlmann previously served as Executive Vice President, Chief Financial Officer and Secretary of Grey Wolf, Inc., a publicly traded oilfield services company, from March 2003. He was Senior Vice President, Chief Financial Officer and Secretary of Grey Wolf, Inc. from February 1998 to March 2003. He joined Grey Wolf in July 1996 and served as Vice President and Controller. From 1991 to 1996, Mr. Wehlmann served in senior accounting roles with EnerVest Management Company L.C., a privately held oil and gas property acquisition and management company, and Convest Energy Corporation, a publicly traded oil and gas exploration and production company. Mr. Wehlmann served as a director of Cano Petroleum, Inc., a publicly traded oil and gas exploration and production company, from December 2007 until September 2010. Mr. Wehlmann is a Certified Public Accountant.
|
Stock transaction information provided by EDGAR Online. Omega Protein, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz
